Masimo Corporation (MASI)
USD 145.06
(-3.52%)
USD 145.06
(-3.52%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.04 Billion USD | -5.27% |
| 2022 | 3.21 Billion USD | 70.14% |
| 2021 | 1.88 Billion USD | 10.19% |
| 2020 | 1.71 Billion USD | 22.66% |
| 2019 | 1.39 Billion USD | 20.9% |
| 2018 | 1.15 Billion USD | 26.87% |
| 2017 | 910.23 Million USD | 10.93% |
| 2016 | 820.52 Million USD | 36.36% |
| 2015 | 601.73 Million USD | 6.5% |
| 2014 | 565 Million USD | 28.8% |
| 2013 | 438.66 Million USD | 16.68% |
| 2012 | 375.94 Million USD | 2.69% |
| 2011 | 366.1 Million USD | 18.01% |
| 2010 | 310.23 Million USD | -12.94% |
| 2009 | 356.34 Million USD | 21.48% |
| 2008 | 293.34 Million USD | 24.56% |
| 2007 | 235.51 Million USD | 48.05% |
| 2006 | 159.07 Million USD | 58.14% |
| 2005 | 100.58 Million USD | 0.0% |
| 2003 | 40.39 Million USD | 23.91% |
| 2002 | 32.6 Million USD | 0.0% |
| 1999 | 24.2 Million USD | 35.2% |
| 1998 | 17.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.89 Billion USD | -2.16% |
| 2024 Q1 | 2.95 Billion USD | -2.76% |
| 2024 Q3 | 3.08 Billion USD | 6.7% |
| 2023 Q4 | 3.04 Billion USD | 1.52% |
| 2023 Q2 | 3.01 Billion USD | -3.35% |
| 2023 Q3 | 2.99 Billion USD | -0.51% |
| 2023 Q1 | 3.11 Billion USD | -2.96% |
| 2023 FY | 3.04 Billion USD | -5.27% |
| 2022 Q1 | 1.9 Billion USD | 1.15% |
| 2022 Q2 | 2.96 Billion USD | 55.13% |
| 2022 Q3 | 3.05 Billion USD | 3.22% |
| 2022 Q4 | 3.21 Billion USD | 5.05% |
| 2022 FY | 3.21 Billion USD | 70.14% |
| 2021 Q1 | 1.59 Billion USD | -6.7% |
| 2021 Q4 | 1.88 Billion USD | 6.81% |
| 2021 Q3 | 1.76 Billion USD | 5.06% |
| 2021 FY | 1.88 Billion USD | 10.19% |
| 2021 Q2 | 1.68 Billion USD | 5.25% |
| 2020 Q2 | 1.63 Billion USD | 10.92% |
| 2020 Q1 | 1.47 Billion USD | 5.62% |
| 2020 FY | 1.71 Billion USD | 22.66% |
| 2020 Q4 | 1.71 Billion USD | -0.03% |
| 2020 Q3 | 1.71 Billion USD | 4.74% |
| 2019 FY | 1.39 Billion USD | 20.9% |
| 2019 Q1 | 1.17 Billion USD | 2.13% |
| 2019 Q4 | 1.39 Billion USD | 6.23% |
| 2019 Q3 | 1.31 Billion USD | 6.86% |
| 2019 Q2 | 1.22 Billion USD | 4.28% |
| 2018 Q4 | 1.15 Billion USD | 5.38% |
| 2018 Q3 | 1.09 Billion USD | 8.79% |
| 2018 FY | 1.15 Billion USD | 26.87% |
| 2018 Q1 | 949.55 Million USD | 4.32% |
| 2018 Q2 | 1 Billion USD | 6.08% |
| 2017 Q1 | 877.66 Million USD | 6.96% |
| 2017 Q4 | 910.23 Million USD | 0.46% |
| 2017 Q3 | 906.07 Million USD | 1.16% |
| 2017 FY | 910.23 Million USD | 10.93% |
| 2017 Q2 | 895.66 Million USD | 2.05% |
| 2016 Q2 | 602.68 Million USD | -2.99% |
| 2016 FY | 820.52 Million USD | 36.36% |
| 2016 Q4 | 820.52 Million USD | 28.32% |
| 2016 Q3 | 639.45 Million USD | 6.1% |
| 2016 Q1 | 621.26 Million USD | 3.25% |
| 2015 Q4 | 601.73 Million USD | 4.14% |
| 2015 FY | 601.73 Million USD | 6.5% |
| 2015 Q1 | 575.22 Million USD | 1.81% |
| 2015 Q2 | 583.61 Million USD | 1.46% |
| 2015 Q3 | 577.78 Million USD | -1.0% |
| 2014 Q2 | 498.75 Million USD | 8.74% |
| 2014 Q1 | 458.65 Million USD | 4.56% |
| 2014 FY | 565 Million USD | 28.8% |
| 2014 Q4 | 565 Million USD | 6.11% |
| 2014 Q3 | 532.46 Million USD | 6.76% |
| 2013 Q1 | 387.82 Million USD | 3.16% |
| 2013 FY | 438.66 Million USD | 16.68% |
| 2013 Q4 | 438.66 Million USD | 2.55% |
| 2013 Q3 | 427.76 Million USD | 7.69% |
| 2013 Q2 | 397.22 Million USD | 2.42% |
| 2012 Q1 | 380.38 Million USD | 3.9% |
| 2012 Q4 | 375.94 Million USD | -8.22% |
| 2012 Q3 | 409.61 Million USD | 7.51% |
| 2012 Q2 | 381 Million USD | 0.16% |
| 2012 FY | 375.94 Million USD | 2.69% |
| 2011 FY | 366.1 Million USD | 18.01% |
| 2011 Q1 | 327.98 Million USD | 5.72% |
| 2011 Q2 | 351.74 Million USD | 7.24% |
| 2011 Q3 | 374.1 Million USD | 6.36% |
| 2011 Q4 | 366.1 Million USD | -2.14% |
| 2010 Q4 | 310.23 Million USD | -5.09% |
| 2010 FY | 310.23 Million USD | -12.94% |
| 2010 Q3 | 326.86 Million USD | 8.72% |
| 2010 Q1 | 291.27 Million USD | -18.26% |
| 2010 Q2 | 300.65 Million USD | 3.22% |
| 2009 FY | 356.34 Million USD | 21.48% |
| 2009 Q1 | 304.9 Million USD | 3.94% |
| 2009 Q4 | 356.34 Million USD | 6.06% |
| 2009 Q3 | 335.98 Million USD | 6.48% |
| 2009 Q2 | 315.53 Million USD | 3.49% |
| 2008 FY | 293.34 Million USD | 24.56% |
| 2008 Q2 | 250.91 Million USD | 10.46% |
| 2008 Q1 | 227.15 Million USD | -3.55% |
| 2008 Q4 | 293.34 Million USD | 8.15% |
| 2008 Q3 | 271.23 Million USD | 8.1% |
| 2007 Q3 | 224.71 Million USD | 29.09% |
| 2007 Q1 | 152.13 Million USD | -4.36% |
| 2007 Q2 | 174.08 Million USD | 14.43% |
| 2007 Q4 | 235.51 Million USD | 4.8% |
| 2007 FY | 235.51 Million USD | 48.05% |
| 2006 Q4 | 159.07 Million USD | 0.0% |
| 2006 FY | 159.07 Million USD | 58.14% |
| 2005 Q4 | 100.58 Million USD | 0.0% |
| 2005 FY | 100.58 Million USD | 0.0% |
| 2003 FY | 40.39 Million USD | 23.91% |
| 2002 FY | 32.6 Million USD | 0.0% |
| 1999 FY | 24.2 Million USD | 35.2% |
| 1998 FY | 17.9 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -1586.265% |
| AngioDynamics, Inc. | 317.67 Million USD | -857.437% |
| AtriCure, Inc. | 613.93 Million USD | -395.413% |
| Avinger, Inc. | 13.77 Million USD | -21987.872% |
| Azenta, Inc. | 2.88 Billion USD | -5.398% |
| BioLife Solutions, Inc. | 412.71 Million USD | -636.951% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 73.913% |
| Daxor Corporation | 34.86 Million USD | -8622.612% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -10417.671% |
| Femasys Inc. | 27.75 Million USD | -10858.06% |
| GlucoTrack, Inc. | 4.9 Million USD | -61908.155% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -2114.158% |
| Hologic, Inc. | 9.15 Billion USD | 66.781% |
| ICU Medical, Inc. | 4.37 Billion USD | 30.535% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 80.303% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -10586.564% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -777.074% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -48808.448% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -48808.448% |
| Microbot Medical Inc. | 8.32 Million USD | -36425.76% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -1669.185% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | -30.803% |
| Nephros, Inc. | 11.86 Million USD | -25542.863% |
| NovoCure Limited | 1.14 Billion USD | -165.372% |
| NEXGEL, Inc. | 9.95 Million USD | -30452.486% |
| NEXGEL, Inc. | 9.95 Million USD | -30452.486% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -1045.717% |
| OraSure Technologies, Inc. | 482.84 Million USD | -529.912% |
| Pro-Dex, Inc. | 54.21 Million USD | -5510.588% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -4902.138% |
| Predictive Oncology Inc. | 14.41 Million USD | -20996.258% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -17883.661% |
| QuidelOrtho Corporation | 8.56 Billion USD | 64.481% |
| Repligen Corporation | 2.82 Billion USD | -7.686% |
| Sanara MedTech Inc. | 73.87 Million USD | -4017.304% |
| STAAR Surgical Company | 488.69 Million USD | -522.376% |
| Sharps Technology, Inc. | 11.78 Million USD | -25698.888% |
| Utah Medical Products, Inc. | 135.45 Million USD | -2145.345% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 58.731% |
| Jin Medical International Ltd. | 32.9 Million USD | -9143.712% |